Erschienen in:
01.02.2008 | Review
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
verfasst von:
Rainer Zenz, Robert Eferl, Clemens Scheinecker, Kurt Redlich, Josef Smolen, Helia B Schonthaler, Lukas Kenner, Erwin Tschachler, Erwin F Wagner
Erschienen in:
Arthritis Research & Therapy
|
Ausgabe 1/2008
Einloggen, um Zugang zu erhalten
Abstract
Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies. The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion. Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology. In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis. These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications.